(Total Views: 493)
Posted On: 06/03/2019 12:30:42 PM
Post# of 74

$SGEN News Article - Seattle Genetics Announces Additional Analyses of ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials of ADCETRIS (Brentuximab Vedotin) at the 2019 ASCO Annual Meeting https://marketwirenews.com/news-releases/seat...89040.html


My Twitter: WhyteStocks